Practical Fragments

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.

26 October 2026

Covalent fragments vs RAB27A/B: towards a chemical probe

›
Last week we highlighted an example of adding a warhead to a fragment-derived, non-covalent protein binder to generate a covalent inhibitor...
19 October 2026

From fragment linking to covalent RAD52 inhibitor

›
Targeting proteins involved in DNA repair is a promising approach against cancer. However, finding effective small molecule inhibitors can b...
12 October 2026

Focal molography for assessing protein-ligand interactions

›
The list of technologies used to find and validate fragments is long, with more than a dozen in our 2024 poll . But it’s always fun to learn...
05 October 2026

Twentieth-Fourth Annual Discovery on Target Meeting

›
Cambridge Healthtech Institute held its annual Discovery on Target ( DoT ) meeting in Boston last week. Attendance may have set a record, wi...
1 comment:
28 September 2026

Expanding the Scope of chemical space at Novartis

›
Without a good library, it is difficult to find a good hit, so library design is one of the most import aspects of a screening campaign. The...
21 September 2026

Design vs randomness in lead optimization across a frustrated landscape

›
The goal of lead optimization is to improve the properties of a molecule such that it can become a drug or a chemical probe . Early in a pro...
5 comments:
14 September 2026

Covalent allosteric inhibitors of NLRP3

›
NLRP3 has received considerable attention as an inflammatory disease target. The protein normally exists in an auto-inhibited conformation, ...
08 September 2026

Computational prediction of cryptic pockets

›
Last week we highlighted how NMR-based fragment screening was able to identify cryptic pockets on a small protein. Experimental methods are...
31 August 2026

Fragments find cryptic sites on ARID1B

›
We’ve written previously about the concept of synthetic lethality, in which changes to one protein make cancer cells more dependent on anot...
24 August 2026

Fragments vs DHX8: towards a chemical probe

›
RNA helicases present an intriguing but challenging opportunity for drug discovery. Their importance for cell growth makes them attractive c...
17 August 2026

Site-specific HDX-MS for increased resolution

›
Most methods to characterize protein-ligand binding interactions have drawbacks. Crystallography, obviously, requires your protein to crysta...
11 August 2026

Filtering fluorescent frauds from fragments for PTP1B

›
Protein tyrosine phosphatase 1B (PTP1B) is a long-standing target for diabetes and other diseases. But as we’ve written previously, it is c...
03 August 2026

Merck’s journey from flatland

›
Back in 2009 we highlighted a paper, “Escape from flatland,” suggesting that molecules with higher fractions of sp 3 -hybridized (ie, non-a...
2 comments:
27 July 2026

Ligand affinities for isolated proteins vs in cells and cell lysates

›
Earlier this year we highlighted a study that compared the affinities of kinase inhibitors for isolated proteins vs those same proteins in ...
20 July 2026

Differential scanning fluorimetry (DSF) for covalent ligands

›
Differential scanning fluorimetry (DSF), also known as a thermal shift assay, is one of the most common techniques for fragment screening ac...
13 July 2026

Fluorine NMR meets make-on-demand libraries

›
Last month Practical Fragments wrote about make-on-demand libraries, such as those offered by Enamine. We’ve also written about fluorine-...
›
Home
View web version
Powered by Blogger.